Table 2 Lifetime experience as a psychedelic practitioner and lifetime psychedelic use (n = 23).
Number of experiences facilitated | |
|---|---|
Mean | 272.39 |
SD | 439.24 |
Median | 100 |
Range | 30–2000 |
N; % substances worked with (most often worked with) | |
Psilocybin mushrooms | 19; 82.6% (5; 21.4%) |
Psilocybin truffles | 9; 39.1% (2; 8.7%) |
Synthetic psilocybin | 5; 21.7% (1; 4.3%) |
Ayahuasca | 13; 56.5% (7; 30.4%) |
DMT | 4; 17.4% (0%) |
Peyote/San Pedro | 8; 34.8% (1; 4.3%) |
LSD | 8; 34.8% (1; 4.3%) |
MDMA | 11; 47.8% (2; 8.7%) |
Ketamine | 9; 39.1% (3; 13%) |
Ibogaine | 1; 4.4% (0%) |
Combination substances | 9; 39.1% (1; 4.3%) |
Other | 2; 8.7% (0%) |
Number of experiences had | |
Mean | 156.96 |
SD | 184.54 |
Median | 100 |
Range | 10–800 |
N; % substances used (N; % most often used) | |
Psilocybin mushrooms | 19; 82.6% (6; 26.1%) |
Psilocybin truffles | 13; 56.5% (0%) |
Synthetic psilocybin | 4; 17.4% (0%) |
Ayahuasca | 21; 91.3% (8; 34.8%) |
DMT | 11; 47.8% (0%) |
Peyote/San Pedro | 19; 82.6% (2; 8.7%) |
LSD | 16; 69.6% (2; 8.7%) |
MDMA | 17; 73.9% (4; 17.4%) |
Ketamine | 14; 60.9% (0%) |
Ibogaine | 2; 8.7% (0%) |
Combination substances | 11; 47.8% (1; 4.3%) |
Other | 7; 30.4% (0%) |
